Weighted Gene Coexpression Network Analysis Identifies TBC1D10C as a New Prognostic Biomarker for Breast Cancer

BACKGROUND: Immune checkpoint inhibitors are a promising therapeutic strategy for breast cancer (BRCA) patients. The tumor microenvironment (TME) can downregulate the immune response to cancer therapy. Our study is aimed at finding a TME-related biomarker to identify patients who might respond to im...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Huiying, Lv, Rong, Pang, Yongkui, Yao, Zhibing, Zhou, Xi, Zhu, Wei, Zhou, Wenqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005324/
https://www.ncbi.nlm.nih.gov/pubmed/35425695
http://dx.doi.org/10.1155/2022/5259187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005324/
https://www.ncbi.nlm.nih.gov/pubmed/35425695
http://dx.doi.org/10.1155/2022/5259187

Ejemplares similares